We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name Doxorubicin-SAA modified lipid nanoparticles-DTPA complex
Catalog Number LNP-137
Size 10 mg; 20 mg; 50 mg
Alias DOX-SAA@LNP-DTPA; Doxorubicin-serum amyloid A modified lipid nanoparticles-diethylenetriaminepentaacetic acid complex,
Appearance Dispersion
Solubility It can be stably dispersed in aqueous solution to form a colloidal system
Description DOX-SAA@LNP-DTPA is a nanocomposite that integrates drug delivery, targeted transport and imaging functions. The complex uses lipid nanoparticles (LNP)as the core carrier. With its good biocompatibility and degradability, it can efficiently encapsulate doxorubicin, effectively protect the drug activity and reduce the side effects of the drug on normal tissues.
Applications MRI contrast agent
Storage 2-8°C, protected from light
Purity 95%+
Shelf Life 1 Year
Shipping Condition Low temperature transport
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket